During the past decade, Presidio Ospedaliero di Livorno conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 7 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Presidio Ospedaliero di Livorno" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Clovis Oncology, Inc." with 2 trials sponsored, "Gruppo di Ricerca GISSI" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Presidio Ospedaliero di Livorno" #1 collaborator was "Agenzia Italiana del Farmaco" with 1 trials as a collaborator, "Dipartimento di scienze chirurgiche, Oncologiche e Gastroenterologiche" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 1 trials as a collaborator and "University of Padova" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Presidio Ospedaliero di Livorno" are "Breast Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Acute Coronary Syndrome" (1 trials), "Atrial Fibrillation" (1 trials) and "Bladder Cancer" (1 trials). Many other conditions were trialed in "Presidio Ospedaliero di Livorno" in a lesser frequency.

Most popular intervention types in "Presidio Ospedaliero di Livorno" are "Drug" (18 trials), "Procedure" (3 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (3 trials), "Placebo" (3 trials), "adjuvant therapy" (3 trials), "Giredestrant" (2 trials) and "LHRH Agonist" (2 trials). Other intervention names were less common.

The vast majority of trials in "Presidio Ospedaliero di Livorno" are 21 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Presidio Ospedaliero di Livorno". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Presidio Ospedaliero di Livorno, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Presidio Ospedaliero di Livorno, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".